T. Fenton

发表

An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children

S. Spector, C. Fletcher, K. Singh, 2005, AIDS.

Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years Old

A. Moscicki, A. Saah, M. Levin, 2010, Journal of acquired immune deficiency syndromes.

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

B. Chi, D. Moodley, G. Theron, 2022, BMC Infectious Diseases.

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.

R. Walker, M. Levin, G. Kemble, 2008, Vaccine.

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.

M. Gersten, L. Mofenson, S. Spector, 1999, The New England journal of medicine.

Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy.

Akihiko Saitoh, S. Spector, C. Fletcher, 2006, The Journal of allergy and clinical immunology.

CONCISE COMMUNICATION Patterns of Plasma Human Immunodeﬁciency Virus Type 1 RNA Response to Highly Active Antiretroviral Therapy in Infected Children

L. Mofenson, S. Spector, C. Fletcher, 2022 .

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement

G. Aldrovandi, M. Boffito, J. Kinuthia, 2020, Clinical pharmacology and therapeutics.

Pharmacokinetics and Pharmacodynamics of Efavirenz and Nelfinavir in HIV‐infected Children Participating in an Area‐under‐the‐curve Controlled Trial

L. Mofenson, S. Spector, C. Fletcher, 2008, Clinical pharmacology and therapeutics.

Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children.

L. Mofenson, S. Spector, C. Fletcher, 2000, The Journal of infectious diseases.

Efavirenz Pharmacokinetics in HIV-1-Infected Children Are Associated With CYP2B6-G516T Polymorphism

S. Spector, C. Fletcher, A. Saitoh, 2007, Journal of acquired immune deficiency syndromes.

Effect of smoking on the activity of ischemic heart disease.

S Campbell, E. Nabel, G. Mudge, 1989, JAMA.